stella
beta
Pembrolizumab Plus Bevacizumab and Chemotherapy for ALK-rearranged NSCLC With Persistent 5'ALK — Stella
Home
/
ALK Gene Mutation
/
View on ClinicalTrials.gov
Recruiting
Back to ALK Gene Mutation trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
Hunan Cancer Hospital, Changsha, Hunan